WO2002038126A3 - Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue - Google Patents
Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue Download PDFInfo
- Publication number
- WO2002038126A3 WO2002038126A3 PCT/DK2001/000715 DK0100715W WO0238126A3 WO 2002038126 A3 WO2002038126 A3 WO 2002038126A3 DK 0100715 W DK0100715 W DK 0100715W WO 0238126 A3 WO0238126 A3 WO 0238126A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- production
- increased bioavailability
- pharmaceutical compositions
- hpmcas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002212102A AU2002212102A1 (en) | 2000-11-08 | 2001-10-29 | A process for production of particles for pharmaceutical compositions having increased bioavailability |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70796600A | 2000-11-08 | 2000-11-08 | |
US09/707,966 | 2000-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002038126A2 WO2002038126A2 (fr) | 2002-05-16 |
WO2002038126A3 true WO2002038126A3 (fr) | 2002-10-10 |
Family
ID=24843867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2001/000715 WO2002038126A2 (fr) | 2000-11-08 | 2001-10-29 | Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002212102A1 (fr) |
WO (1) | WO2002038126A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103153343B (zh) * | 2010-06-14 | 2015-02-11 | 陶氏环球技术有限责任公司 | 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯 |
US9084727B2 (en) | 2011-05-10 | 2015-07-21 | Bend Research, Inc. | Methods and compositions for maintaining active agents in intra-articular spaces |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
US8207232B2 (en) * | 2004-05-28 | 2012-06-26 | Bend Research, Inc. | Pharmaceutical compositions with enhanced performance |
CA2810655C (fr) | 2004-06-24 | 2013-12-10 | Vertex Pharmaceuticals Incorporated | Modulateurs de transporteurs de cassette de liaison a l'atp |
EP3708564A1 (fr) | 2005-12-28 | 2020-09-16 | Vertex Pharmaceuticals Incorporated | Une forme solide de n-[2,4-bis(1,1-diméthyléthyl)-5-hydroxyphényl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
KR101852173B1 (ko) | 2009-03-20 | 2018-04-27 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법 |
CN104470518A (zh) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | 药物组合物及其施用 |
JP6746569B2 (ja) | 2014-10-07 | 2020-08-26 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | 嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0344603A1 (fr) * | 1988-05-30 | 1989-12-06 | Zeria Pharmaceutical Co., Ltd. | Composition pharmaceutique contenant un dérivé de la dihydropyridine |
WO1993000991A1 (fr) * | 1991-07-03 | 1993-01-21 | Smithkline Beecham Plc | Procede de preparation de substances medicamenteuses sous forme de granules |
WO1995020432A1 (fr) * | 1994-01-27 | 1995-08-03 | Aeromatic-Fielder Ag | Dispositif d'enrobage de particules solides |
EP0901786A2 (fr) * | 1997-08-11 | 1999-03-17 | Pfizer Products Inc. | Dispersions solides pharmaceutiques à biodisponibilité accrue |
US5985322A (en) * | 1997-05-29 | 1999-11-16 | Eli Lilly And Company | Method for the treatment of CNS disorders |
WO2000040339A1 (fr) * | 1998-12-30 | 2000-07-13 | Aeromatic-Fielder Ag | Appareil et procede d'enrobage de comprimes |
-
2001
- 2001-10-29 WO PCT/DK2001/000715 patent/WO2002038126A2/fr active Application Filing
- 2001-10-29 AU AU2002212102A patent/AU2002212102A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0344603A1 (fr) * | 1988-05-30 | 1989-12-06 | Zeria Pharmaceutical Co., Ltd. | Composition pharmaceutique contenant un dérivé de la dihydropyridine |
WO1993000991A1 (fr) * | 1991-07-03 | 1993-01-21 | Smithkline Beecham Plc | Procede de preparation de substances medicamenteuses sous forme de granules |
WO1995020432A1 (fr) * | 1994-01-27 | 1995-08-03 | Aeromatic-Fielder Ag | Dispositif d'enrobage de particules solides |
US5985322A (en) * | 1997-05-29 | 1999-11-16 | Eli Lilly And Company | Method for the treatment of CNS disorders |
EP0901786A2 (fr) * | 1997-08-11 | 1999-03-17 | Pfizer Products Inc. | Dispersions solides pharmaceutiques à biodisponibilité accrue |
WO2000040339A1 (fr) * | 1998-12-30 | 2000-07-13 | Aeromatic-Fielder Ag | Appareil et procede d'enrobage de comprimes |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103153343B (zh) * | 2010-06-14 | 2015-02-11 | 陶氏环球技术有限责任公司 | 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯 |
US9084727B2 (en) | 2011-05-10 | 2015-07-21 | Bend Research, Inc. | Methods and compositions for maintaining active agents in intra-articular spaces |
Also Published As
Publication number | Publication date |
---|---|
AU2002212102A1 (en) | 2002-05-21 |
WO2002038126A2 (fr) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002038126A3 (fr) | Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue | |
WO2003043574A3 (fr) | Compositions pharmaceutiques sous forme particulaire | |
NZ506241A (en) | Solid cyclodextrin flavor delivery systems | |
WO2004098561A3 (fr) | Materiaux particulaires | |
AU4859601A (en) | Particulate composition | |
WO2005102269A3 (fr) | Preparations a liberation lente et leur procede de production | |
WO2002043702A3 (fr) | Compositions pharmaceutiques pour inhalation | |
WO2004012700A3 (fr) | Nouvelle forme galenique | |
HUP0202062A2 (hu) | Eljárás maszkírozott ízű és azonnali hatóanyag-leadású bevont szemcsék előállítására | |
WO2002074238A3 (fr) | Complexes hydrosolubles et palatables | |
WO2002082902A3 (fr) | Formulation granulaire concentree soluble dans l'eau regulatrice de la croissance des plantes et procedes d'utilisation | |
AU2003291973A1 (en) | A self-cleaning spray nozzle | |
NZ527585A (en) | Tablets quickly disintegrated in oral cavity | |
WO2005079755A3 (fr) | Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes | |
WO2006089674A3 (fr) | Comprimés présentant une dispersibilité de substance médicamenteuse améliorée | |
CA2514446A1 (fr) | Composition comprenant un melange de principes actifs et methode pour la preparer | |
CA2430318A1 (fr) | Formulation pulverulente et son procede de production | |
GR3023242T3 (en) | Process for the preparation of solid sustained release pharmaceutical forms | |
WO2001037816A3 (fr) | Enrobage | |
EP1238662A3 (fr) | Procédé de fabrication de granules d' un médicament, les granules du médicament et des préparations pharmaceutiques contenant ces granules | |
CA2192086A1 (fr) | Pilules | |
WO2004030649A3 (fr) | Procede pour preparer et stabiliser des microsuspensions et des nanosuspensions au moyen d'amphiphiles et de polyelectrolytes | |
AU2001262011A1 (en) | A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component | |
CA2390746A1 (fr) | Composition pharmaceutique a bse de derives de quinolinone et methode pour sa production | |
CA2356959A1 (fr) | Systeme de distribution de medicament insoluble dans l'eau |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |